Rajko Reljic Selected Research

Tuberculosis (Tuberculoses)

10/2023	Design and Characterization of a Multistage Peptide-Based Vaccine Platform to Target Mycobacterium tuberculosis Infection.
1/2023	Spore-FP1 tuberculosis mucosal vaccine candidate is highly protective in guinea pigs but fails to improve on BCG-conferred protection in non-human primates.
1/2023	Role of phagocyte extracellular traps during Mycobacterium tuberculosis infections and tuberculosis disease processes.
5/2020	Design of Polymeric Nanocapsules for Intranasal Vaccination against Mycobacterium Tuberculosis: Influence of the Polymeric Shell and Antigen Positioning.
1/2020	Adaption of the ex vivo mycobacterial growth inhibition assay for use with murine lung cells.
1/2020	An RNA-seq Based Machine Learning Approach Identifies Latent Tuberculosis Patients With an Active Tuberculosis Profile.
1/2020	Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γ.
1/2020	Changes in the Immune Phenotype and Gene Expression Profile Driven by a Novel Tuberculosis Nanovaccine: Short and Long-Term Post-immunization.
12/2019	Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges.
8/2019	Emerging Themes for the Role of Antibodies in Tuberculosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rajko Reljic Research Topics

Disease

32	Tuberculosis (Tuberculoses) 10/2023 - 03/2004
23	Infections 02/2024 - 03/2004
6	Communicable Diseases (Infectious Diseases) 01/2019 - 03/2011
5	Dengue (Dengue Fever) 01/2024 - 04/2015
3	Latent Tuberculosis 01/2020 - 05/2007
2	Inflammation (Inflammations) 01/2020 - 01/2019
2	Granuloma 03/2009 - 01/2009
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2023
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	Neoplasms (Cancer) 01/2019
1	Pulmonary Tuberculosis 01/2019
1	Leprosy (Hansen's Disease) 01/2018
1	Leishmaniasis 01/2018
1	Melioidosis 01/2018
1	Virus Diseases (Viral Diseases) 04/2015

Drug/Important Bio-Agent (IBA)

21	VaccinesIBA 02/2024 - 03/2011
13	AntigensIBA 01/2024 - 03/2004
8	AntibodiesIBA 01/2024 - 03/2004
7	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2014
7	Immunoglobulin A (IgA)IBA 01/2020 - 03/2004
6	CytokinesIBA 07/2010 - 05/2006
3	Peptides (Polypeptides)IBA 01/2024 - 01/2019
3	alpha-Crystallins (alpha-Crystallin)IBA 01/2020 - 03/2004
3	Monoclonal AntibodiesIBA 03/2011 - 03/2004
2	Immunoglobulin G (IgG)IBA 01/2024 - 01/2018
2	Cholera ToxinIBA 01/2024 - 10/2016
2	Interferon-gamma (Interferon, gamma)IBA 01/2020 - 05/2006
2	NanovaccinesIBA 01/2020 - 01/2019
2	ChemokinesIBA 03/2009 - 01/2009
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2009 - 03/2007
2	Interleukin-4 (Interleukin 4)IBA 01/2009 - 03/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	IronIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	IgA receptor (protein B)IBA 01/2020
1	LipidsIBA 01/2020
1	Apoprotein(a) (Apolipoprotein (a))IBA 01/2020
1	InterferonsIBA 01/2020
1	Transferrin (beta 2 Transferrin)IBA 01/2020
1	BCG Vaccine FDA Link 12/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	CarbohydratesIBA 01/2019
1	Liposomes (Liposome)IBA 01/2019
1	Subunit VaccinesIBA 01/2019
1	PhosphatidylserinesIBA 01/2019
1	Ag85B-ESAT-6 fusion antigenIBA 01/2019
1	Glycoproteins (Glycoprotein)IBA 12/2017
1	Combined VaccinesIBA 10/2016
1	Antigen-Antibody Complex (Immune Complex)IBA 04/2015
1	EpitopesIBA 04/2015
1	DEC-205 receptorIBA 03/2011
1	Protein Subunit VaccinesIBA 03/2011
1	LuciferasesIBA 03/2011
1	Therapeutic UsesIBA 03/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2009
1	serum P-component (CIt)IBA 01/2009
1	lipoarabinomannan (LAM)IBA 12/2006
1	DNA VaccinesIBA 05/2006
1	AerosolsIBA 03/2004

Therapy/Procedure

4	Therapeutics 01/2020 - 05/2007
4	Immunotherapy 01/2019 - 05/2006
2	Drug Therapy (Chemotherapy) 01/2009 - 05/2007
1	Art Therapy 01/2023